Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
11/2007
11/22/2007WO2007131991A1 Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases
11/22/2007WO2007103432A3 Use of pyrazolo[1,5a]pyrimidin-7-yl amine derivatives in the treatment of neurological disorders
11/22/2007WO2007096807A9 Process for the preparation of zaleplon and an intermediate thereof
11/22/2007WO2007047925A3 Swallowtail motifs for imparting water solubility to porphyrinic compounds
11/22/2007WO2006104915A3 8-PHENYL-7,8-DIHYDROPYRIDO[2,3-d]PYRIMIDIN-7-ONES AND THEIR USE AS PHARMACEUTICALS
11/22/2007WO2006091394A3 Substituted imidazoquinolines and imidazonaphthyridines
11/22/2007WO2006074003A3 CHIRAL FUSED [1,2]IMIDAZO[4,5-c] RING COMPOUNDS
11/22/2007WO2005046589A3 Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties
11/22/2007US20070270590 Methods for preparing eszopiclone crystalline form a, substantially pure eszopiclone and optically enriched eszopiclone
11/22/2007US20070270588 Pyrrolopyrimidine Derivatives
11/22/2007US20070270587 Pyrimidoindolones and methods for using same
11/22/2007US20070270474 Pyrazole compounds for treatment of neurodegenerative disorders
11/22/2007US20070270445 Diaminopyrroloquinazolines compounds as protein tyrosine phosphatase inhibitors
11/22/2007US20070270444 (5-Methyl-2H-pyrazol-3-yl)-(2-phenylsulfanyl-quinazolin-4-yl)-amine; Anticancer agents; antidiabetic agents; Alzheimer's disease; inhibitors of Aurora-2 and GSK-3
11/22/2007US20070270421 Hepatocyte growth factor receptor inhibitors; Antitumor agents, anticarcinogenic agents, angiogenesis inhibitors; pyrimidine derivatives like Pyrrolidine-1-carboxylic acid [6-(2-fluoro-4-{3-[2-(4-fluorophenyl)acetyl]thioureido}phenoxy)pyrimidin-4-yl]amide
11/22/2007US20070270420 Heteroaryl compounds useful as inhibitors of gsk-3
11/22/2007US20070270419 Pyridinylpyrazolopyrimidinone derivatives as pde 7 inhibitors
11/22/2007US20070270412 Novel pharmaceuticals
11/22/2007US20070270406 Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors
11/22/2007US20070270405 Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors
11/22/2007US20070270311 6-Phenyl-7-Aminotriazolopyrimidines, Processes For Their Preparation And Their Use For Controlling Harmful Fungi, And Also Compositions Comprising Them
11/22/2007US20070267968 Electronic devices made with electron transport and/or anti-quenching layers
11/22/2007CA2650273A1 Monocyclic heteroaryl compounds
11/21/2007EP1857459A2 Pyrazolopyrimidine compound and a process for preparing the same
11/21/2007EP1856123A2 Small molecule inhibitors of mdm2 and uses thereof
11/21/2007EP1856122A2 2-substituted 7-amino-azolopyrimidine, a method for the production and use thereof for controlling pathogenic fungi and agents containing said compound
11/21/2007EP1856121A1 5,6-dialkyl-7-amino-azolopyrimidines, method for their production, their use for controlling pathogenic fungi and agents containing said compounds
11/21/2007EP1856120A1 5,6-dialkyl-7-amino-azolopyrimidines, method for their production, their use for controlling pathogenic fungi and agents containing said compounds
11/21/2007EP1856119A1 5,6-dialkyl-7-amino-azolopyrimidines, method for their production, their use for controlling pathogenic fungi and agents containing said compounds
11/21/2007EP1856118A1 5,6-dialkyl-7-amino-azolopyrimidines, methods for the production thereof, use thereof for controlling harmful fungi, and substances containing the same
11/21/2007EP1856077A1 Piperazine derivatives as glyt1 inhibitors
11/21/2007EP1856058A2 Phthalazine, aza- and diaza-phthalazine compounds and methods of use
11/21/2007EP1856049A1 Biphenyl compounds useful as muscarinic receptor antagonists
11/21/2007EP1855529A2 Spiroketal-substituted cyclic ketoenols
11/21/2007EP1697378B1 Indoles, 1h-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereof
11/21/2007EP1595143A4 The detection and identification of saxiphilins using saxitoxin-biotin conjugates
11/21/2007EP1578750B1 Cationic porphyrin derivatives as antibacterial agents
11/21/2007EP1474139B1 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
11/21/2007EP1458383B1 Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5
11/21/2007EP1330440B1 Agent which inactivates pathogens, comprising an element that bonds with nucleic acids and the use thereof
11/21/2007EP1281711B1 Interstrand crosslinking agents for dna and compounds therefor
11/21/2007CN101076532A Bi- and tricyclic substituted phenyl methanones as glycine transporter i (glyt-1) inhibitors for the treatment of alzheimer's disease.
11/21/2007CN101076531A Carboxylic acid peri-substituted bicyclics for occlusive artery disease
11/21/2007CN101076333A Pyrazolo-heteroaryl compounds useful to treat TNF-alpha and IL-1 mediated diseases
11/21/2007CN101074210A Pharmaceutically active isoindoline derivatives
11/21/2007CN101073780A Phase-transferring catalyst containing dinaphthalene chiral double-spiral quaternary ammonium and its production
11/21/2007CN100349895C Pyrrolopyridazine derivatives
11/21/2007CN100349517C Fused heterocyclic sulfonylurea compound, herbicide containing the same and method of controlling weed with the same
11/20/2007US7297792 Pyrazolopyridines and pyrazolopyridazines as antidiabetics
11/20/2007US7297789 From 4-amino-2-methyl-10H-thieno(2,3-b)(1,5) benzodiazpine HCl and 1-methylpiperazine in an aprotic high boiling solvent; purifying in an acid medium; basifying to pH of 7.5-9; and extracting with a low boiling organic solvent
11/20/2007US7297711 Arylalkyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them
11/20/2007US7297701 Anti-cancer cyclopenta [G]quinazoline compounds
11/20/2007US7297695 Anticancer agents; inhibits tyrosine kinase activity of growth factor receptors; antiproliferative agents
11/15/2007WO2007131153A2 Methods for the preparation of pyrazole-containing compounds
11/15/2007WO2007131020A2 Constrained compounds as cgrp-receptor antagonists
11/15/2007WO2007130927A2 Condensed tricyclic compounds as cgrp-receptor antagonists
11/15/2007WO2007130860A2 Constrained compounds as cgrp-receptor antagonists
11/15/2007WO2007130825A2 Fused heterocyclic compounds and their use as mglur5 modulators
11/15/2007WO2007129119A1 Pentacyclic indole derivatives as antiviral agents
11/15/2007WO2007129060A1 Tetrahydropyrrolopyrimidinediones and their use as human neutrophil elastase inhibitors
11/15/2007WO2007128752A1 Pyridyl compounds
11/15/2007WO2007128410A1 Insecticidal compounds
11/15/2007WO2007109355A3 6,7,8, 9 -tetrahydro- 5h- pyrimido [4, 5-d] azepin-4-yl] -amine derivatives as modulators of trpvl for the treatment of pain
11/15/2007WO2007099171A3 Bicyclo-pyrazoles active as kinase inhibitors
11/15/2007WO2007077186A8 Pdf inhibitors
11/15/2007WO2007076092A3 Nitrogen- containing bicyclic hetroaryl compounds for the treatment of raf protein kinase-mediated diseases
11/15/2007WO2007061764A3 Tricyclic compounds useful as inhibitors of kinases
11/15/2007WO2007058942A3 Imidazopyrazines as protein kinase inhibitors
11/15/2007WO2007056469A3 Certain chemical entities, compositions, and methods
11/15/2007WO2006124354A3 Tyrosine kinase inhibitors
11/15/2007US20070265444 Novel Inhibitors of Folic Acid-Dependent Enzymes
11/15/2007US20070265328 2-(6-oxo-1,7-diaza-spiro[4.4]non-7-yl)-propionamides such as 4-(S)-hydroxy-5-(S)-[2-(S)-(1-isobutyl-6-oxo-1,7-diaza-spiro(S)-[4.4]non-7-yl)-propionylamino]-2-(R)-methyl-6-phenyl-hexanoic acid butylamide; inhibitors of aspartic proteases such as beta-secretase
11/15/2007US20070265283 Xanthine Oxidase Inhibitor
11/15/2007US20070265282 Use of ticagrelor treating myocardial infarction, thrombotic stroke, angina and transient ischemic attacks
11/15/2007US20070265272 2-[4-(3-Quinolin-6-ylmethyl-3H-[1,2,3]triazolo[4,5-b]pyrazin-5-yl)-pyrazol-1-yl]-ethanol, for example; for treating hyperproliferative disorders
11/15/2007US20070265248 Substituted piperazines and methods of use
11/15/2007US20070265244 2-[1-(1-carboxymethyl-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-3-ylcarbamoyl)-cyclopentylmethyl]-N-(3-dimethylamino-propyl)-N-methyl-succinamic acid, or a biolabile ester thereof; neutral endopeptidase and/or human soluble endopeptidase (hSEP) inhibitors; cardiovascular diseases, apoptosis e.g. stroke
11/15/2007US20070265241 Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance
11/15/2007US20070265202 Compounds That Modulate Trh Actions
11/15/2007US20070265193 Tetraazabenzo[e]azulene derivatives and analogs thereof
11/15/2007CA2657956A1 Tetrahydropyrrolopyrimidinediones and their use as human neutrophil elastase inhibitors
11/15/2007CA2651226A1 Pentacyclic indole derivatives as antiviral agents
11/15/2007CA2651033A1 Constrained compounds as cgrp-receptor antagonists
11/15/2007CA2650255A1 Mglur5 modulators v
11/14/2007EP1854797A1 Process for preparing cyameluric chloride
11/14/2007EP1854796A1 Optically active ammonium salt compound, production intermediate thereof and method for producing same
11/14/2007EP1853618A1 Tricyclic-nucleoside compounds for treating viral infections
11/14/2007EP1853617A1 Tricyclic-nucleoside prodrugs for treating viral infections
11/14/2007EP1853608A1 5-alkoxyalkyl-6-alkyl-7-amino-azolopyrimidines, method for their production, their use for controlling pathogenic fungi and agents containing said substances
11/14/2007EP1853607A2 Pyrazolopyrimidines
11/14/2007EP1758871B1 Pyrazolo pyrimidines
11/14/2007EP1664043B1 Compositions useful as inhibitors of protein kinases
11/14/2007EP1427722B1 Pyrrole-type compounds, compositions, and methods for treating cancer, treating viral diseases and causing immunosuppression
11/14/2007EP1409480B1 Pyrrolo-indole and pyrrolo-quinoline derivatives as prodrugs for tumour treatment
11/14/2007CN101072779A 2,4 (4,6) pyrimidine derivatives
11/14/2007CN101072778A Novel pyrrolo [3, 2-d] pyrimidin-4-one derivatives and their use in therapy
11/14/2007CN101072770A Tetrahydropyridin-4-yl indoles with a combination of affinity for dopamine-D2 receptors and serotonin reuptake sites
11/14/2007CN101070323A Porphyrin derivative, its preparing method and use of same as small-molecular anti-oxidation agent
11/14/2007CN101070309A Substituted piperazines (1,4) diaszepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists
11/14/2007CN101070302A Synthesis of phenolic monomers containing imide or diimide moieties and high heat carbonate polymers prepared therefrom
1 ... 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 ... 573